CIK 0001850270 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 4 Open-market sale 10% owner sold 391,400 shares at an average $1.65 ($645,514)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 321,473 shares at an average $1.77 ($567,573)
- 4 Open-market sale 10% owner sold 447,500 shares at an average $2.01 ($899,963)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 447,043 shares at an average $2.70 ($1,205,390)
- 4 Open-market sale 10% owner sold 486,863 shares at an average $2.86 ($1,391,817)
- 4 Open-market sale 10% owner sold 277,621 shares at an average $4.42 ($1,227,466)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 1,700,000 shares at $5.47 ($9,299,000)
- 8-K Event Regulation FD disclosure
- 4 Conversion SVP of Regulatory Development acquired 137,000 shares (conversion)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 424B3 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
Page 11 of 21 · 406 filings